Gilead v AMMS – the UPC Further Develops its Inventive-Step Framework
In its decision of 4 May 2026 (UPC_CFI_552/2025), the Milan Central Division revoked EP 3 854 403 B1, a patent directed to the use of remdesivir for the treatment of […]Read more
Our area of expertise is not limited to industrial property, but extends to all intellectual property matters. We can indeed advise clients on:
Patents by drafting, filing and prosecuting applications directly before the European Patent Office and some national European Offices, as well as around the world via PCT applications and through our extensive network of foreign associates...
Discover our firmIn its decision of 4 May 2026 (UPC_CFI_552/2025), the Milan Central Division revoked EP 3 854 403 B1, a patent directed to the use of remdesivir for the treatment of […]Read more
WARNING: We have been notified by some of our clients that they received a letter from a Dutch firm COHEN KLEIN & ASSOCIATES, in which said firm proposes renewal services […]Read more
Luxembourg, July 2026 — Office Freylinger is proud to announce its continued recognition in the Managing IP IP STARS 2026 rankings, reinforcing its reputation as a trusted European intellectual property […]Read more
European design law is facing a comprehensive modernization. Given the rapid digital transformation and the necessity to adapt protection mechanisms to new technologies such as 3D printing and interactive user […]Read more
In an interesting and quite unusual case, Office Freylinger was able to defend the interests of the Luxembourg Animal Protection Association Lëtzebuerger Déiereschutzliga in Germany. We assisted our client in […]Read more
Martin Gutwillinger will be attending the 2026 ECTA 44th Annual Conference in Dublin from June 16th to June 19th 2026 Martin is eagerly looking forward to reconnecting with colleagues and […]Read more
Loret ipsumRead more